A retrospective study to determine effectiveness of COVID vaccine and antibody response in immunosuppressed pediatric systemic lupus erythematosus patients
Latest Information Update: 30 Dec 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 30 Dec 2022 New trial record
- 14 Nov 2022 Results presented at the ACR Convergence 2022